$ITCI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Intra-Cellular Therapies, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Intra-Cellular Therapies, Inc.. Get notifications about new insider transactions in Intra-Cellular Therapies, Inc. for free.
Page: < prev 1 2 3 4 5 6 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Option Exercise | M | 0.00 | 5,297 | 0 | 10,596 | |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Sell | S | 17.49 | 1,870 | 32,706 | 66,732 | 68.6 K to 66.7 K (-2.73 %) |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Sell | S | 15.67 | 3,192 | 50,019 | 68,602 | 71.8 K to 68.6 K (-4.45 %) |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Buy | M | 0.00 | 3,108 | 0 | 71,794 | 68.7 K to 71.8 K (+4.52 %) |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Buy | M | 0.00 | 5,297 | 0 | 68,686 | 63.4 K to 68.7 K (+8.36 %) |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Halstead Michael | SVP and General Cou ... | Option Exercise | A | 0.00 | 48,480 | 0 | 48,480 | |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Halstead Michael | SVP and General Cou ... | Option Exercise | A | 15.47 | 65,164 | 1,008,087 | 65,164 | |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Halstead Michael | SVP and General Cou ... | Option Exercise | M | 0.00 | 3,108 | 0 | 3,108 | |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Halstead Michael | SVP and General Cou ... | Option Exercise | M | 0.00 | 5,297 | 0 | 10,596 | |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Halstead Michael | SVP and General Cou ... | Sell | S | 17.49 | 1,560 | 27,284 | 25,691 | 27.3 K to 25.7 K (-5.72 %) |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Halstead Michael | SVP and General Cou ... | Sell | S | 15.75 | 2,660 | 41,895 | 27,251 | 29.9 K to 27.3 K (-8.89 %) |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Halstead Michael | SVP and General Cou ... | Buy | M | 0.00 | 3,108 | 0 | 29,911 | 26.8 K to 29.9 K (+11.60 %) |
| Jan 05 2018 | ITCI | Intra-Cellular The ... | Halstead Michael | SVP and General Cou ... | Buy | M | 0.00 | 5,297 | 0 | 26,803 | 21.5 K to 26.8 K (+24.63 %) |
| Jan 03 2018 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Buy | P | 14.48 | 1,001 | 14,494 | 36,608 | 35.6 K to 36.6 K (+2.81 %) |
| Jan 03 2018 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Buy | P | 14.48 | 949 | 13,742 | 9,570 | 8.6 K to 9.6 K (+11.01 %) |
| Dec 13 2017 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Option Exercise | M | 1.50 | 12,500 | 18,750 | 0 | |
| Dec 13 2017 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Sell | S | 15.09 | 7,000 | 105,630 | 53,000 | 60 K to 53 K (-11.67 %) |
| Dec 13 2017 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Buy | M | 1.50 | 12,500 | 18,750 | 60,000 | 47.5 K to 60 K (+26.32 %) |
| Dec 06 2017 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Option Exercise | M | 0.00 | 1,757 | 0 | 1,758 | |
| Dec 06 2017 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Sell | S | 15.00 | 650 | 9,750 | 27,864 | 28.5 K to 27.9 K (-2.28 %) |
| Dec 06 2017 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Buy | M | 0.00 | 1,757 | 0 | 28,514 | 26.8 K to 28.5 K (+6.57 %) |
| Nov 27 2017 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 15.55 | 10,000 | 155,500 | 744,466 | 734.5 K to 744.5 K (+1.36 %) |
| Nov 15 2017 | ITCI | Intra-Cellular The ... | Satlin Andrew | EVP and Chief Medic ... | Option Exercise | A | 14.79 | 170,500 | 2,521,695 | 170,500 | |
| Nov 01 2017 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 1.50 | 18,750 | 28,125 | 0 | |
| Nov 01 2017 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 15.75 | 18,750 | 295,313 | 1,088,707 | 1.1 M to 1.1 M (-1.69 %) |
| Nov 01 2017 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 1.50 | 18,750 | 28,125 | 1,107,457 | 1.1 M to 1.1 M (+1.72 %) |
| Oct 03 2017 | ITCI | Intra-Cellular The ... | VAN NOSTRAND ROBERT L | Director | Grant | A | 0.00 | 316 | 0 | 3,311 | 3 K to 3.3 K (+10.55 %) |
| Oct 03 2017 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 0.00 | 918 | 0 | 35,607 | 34.7 K to 35.6 K (+2.65 %) |
| Oct 03 2017 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Grant | A | 0.00 | 871 | 0 | 8,621 | 7.8 K to 8.6 K (+11.24 %) |
| Oct 03 2017 | ITCI | Intra-Cellular The ... | ALAFI MOSHE | 10% Owner | Buy | P | 15.50 | 258,065 | 4,000,008 | 3,953,270 | 3.7 M to 4 M (+6.98 %) |
| Oct 03 2017 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 15.50 | 258,065 | 4,000,008 | 3,953,270 | 3.7 M to 4 M (+6.98 %) |
| Oct 03 2017 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 0.00 | 918 | 0 | 734,466 | 733.5 K to 734.5 K (+0.13 %) |
| Oct 03 2017 | ITCI | Intra-Cellular The ... | ALAFI CAPITAL CO LLC | 10% Owner | Buy | P | 15.50 | 258,065 | 4,000,008 | 3,953,270 | 3.7 M to 4 M (+6.98 %) |
| Jul 05 2017 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 0.00 | 1,167 | 0 | 733,548 | 732.4 K to 733.5 K (+0.16 %) |
| Jun 29 2017 | ITCI | Intra-Cellular The ... | VAN NOSTRAND ROBERT L | Director | Option Exercise | A | 12.45 | 20,000 | 249,000 | 20,000 | |
| Jun 29 2017 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Option Exercise | A | 12.45 | 20,000 | 249,000 | 20,000 | |
| Jun 29 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | A | 12.45 | 20,000 | 249,000 | 20,000 | |
| Jun 29 2017 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Option Exercise | A | 12.45 | 20,000 | 249,000 | 20,000 | |
| Jun 29 2017 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Option Exercise | A | 12.45 | 20,000 | 249,000 | 20,000 | |
| Apr 04 2017 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 0.00 | 892 | 0 | 33,522 | 32.6 K to 33.5 K (+2.73 %) |
| Apr 04 2017 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 0.00 | 892 | 0 | 732,381 | 731.5 K to 732.4 K (+0.12 %) |
| Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | M | 1.50 | 12,500 | 18,750 | 0 | |
| Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | M | 1.50 | 12,500 | 18,750 | 0 | |
| Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | M | 2.74 | 12,500 | 34,250 | 0 | |
| Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | M | 2.74 | 12,500 | 34,250 | 0 | |
| Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | M | 2.84 | 12,500 | 35,500 | 0 | |
| Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | M | 3.26 | 12,500 | 40,750 | 0 | |
| Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | M | 3.26 | 20,000 | 65,200 | 0 | |
| Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Gift | G | 0.00 | 95,000 | 0 | 110,742 | 15.7 K to 110.7 K (+603.48 %) |
| Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Gift | G | 0.00 | 95,000 | 0 | 21,671 | 116.7 K to 21.7 K (-81.43 %) |
| Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Buy | M | 1.50 | 12,500 | 18,750 | 116,671 | 104.2 K to 116.7 K (+12.00 %) |
| Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Buy | M | 1.50 | 12,500 | 18,750 | 104,171 | 91.7 K to 104.2 K (+13.64 %) |
| Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Buy | M | 2.74 | 12,500 | 34,250 | 91,671 | 79.2 K to 91.7 K (+15.79 %) |
| Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Buy | M | 2.74 | 12,500 | 34,250 | 79,171 | 66.7 K to 79.2 K (+18.75 %) |
| Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Buy | M | 2.84 | 12,500 | 35,500 | 66,671 | 54.2 K to 66.7 K (+23.08 %) |
| Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Buy | M | 3.26 | 12,500 | 40,750 | 54,171 | 41.7 K to 54.2 K (+30.00 %) |
| Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Buy | M | 3.26 | 20,000 | 65,200 | 41,671 | 21.7 K to 41.7 K (+92.29 %) |
| Jan 09 2017 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Sell | S | 16.59 | 800 | 13,272 | 10,128 | 10.9 K to 10.1 K (-7.32 %) |
| Jan 09 2017 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Sell | S | 16.55 | 4,081 | 67,541 | 1,088,707 | 1.1 M to 1.1 M (-0.37 %) |
| Jan 09 2017 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Sell | S | 16.58 | 1,918 | 31,800 | 63,389 | 65.3 K to 63.4 K (-2.94 %) |
| Jan 09 2017 | ITCI | Intra-Cellular The ... | Halstead Michael | SVP and General Cou ... | Sell | S | 16.55 | 1,601 | 26,497 | 21,506 | 23.1 K to 21.5 K (-6.93 %) |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Option Exercise | M | 0.00 | 1,553 | 0 | 3,108 | |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Option Exercise | A | 0.00 | 7,946 | 0 | 7,946 | |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Option Exercise | A | 15.73 | 31,858 | 501,126 | 31,858 | |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Buy | M | 0.00 | 1,553 | 0 | 10,928 | 9.4 K to 10.9 K (+16.57 %) |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | M | 0.00 | 6,603 | 0 | 13,208 | |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | A | 0.00 | 33,773 | 0 | 33,773 | |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | A | 15.73 | 135,399 | 2,129,826 | 135,399 | |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Buy | M | 0.00 | 6,603 | 0 | 1,092,788 | 1.1 M to 1.1 M (+0.61 %) |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Option Exercise | M | 0.00 | 3,107 | 0 | 6,216 | |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Option Exercise | A | 0.00 | 15,893 | 0 | 15,893 | |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Option Exercise | A | 15.73 | 63,717 | 1,002,268 | 63,717 | |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Buy | M | 0.00 | 3,107 | 0 | 65,307 | 62.2 K to 65.3 K (+5.00 %) |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Halstead Michael | SVP and General Cou ... | Option Exercise | M | 0.00 | 3,107 | 0 | 6,216 | |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Halstead Michael | SVP and General Cou ... | Option Exercise | A | 0.00 | 15,893 | 0 | 15,893 | |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Halstead Michael | SVP and General Cou ... | Option Exercise | A | 15.73 | 63,717 | 1,002,268 | 63,717 | |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Halstead Michael | SVP and General Cou ... | Buy | M | 0.00 | 3,107 | 0 | 23,107 | 20 K to 23.1 K (+15.54 %) |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Option Exercise | A | 0.00 | 7,946 | 0 | 7,946 | |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Option Exercise | A | 15.73 | 31,858 | 501,126 | 31,858 | |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Option Exercise | M | 0.00 | 1,757 | 0 | 3,515 | |
| Jan 05 2017 | ITCI | Intra-Cellular The ... | Davis Robert E | SVP, Chief Scientif ... | Buy | M | 0.00 | 1,757 | 0 | 26,757 | 25 K to 26.8 K (+7.03 %) |
| Jan 03 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Grant | A | 0.00 | 994 | 0 | 21,671 | 20.7 K to 21.7 K (+4.81 %) |
| Jan 03 2017 | ITCI | Intra-Cellular The ... | VAN NOSTRAND ROBERT L | Director | Grant | A | 0.00 | 331 | 0 | 2,286 | 2 K to 2.3 K (+16.93 %) |
| Jan 03 2017 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 0.00 | 960 | 0 | 32,630 | 31.7 K to 32.6 K (+3.03 %) |
| Jan 03 2017 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Grant | A | 0.00 | 911 | 0 | 5,797 | 4.9 K to 5.8 K (+18.65 %) |
| Jan 03 2017 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 0.00 | 960 | 0 | 731,489 | 730.5 K to 731.5 K (+0.13 %) |
| Dec 19 2016 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Option Exercise | M | 1.50 | 3,750 | 5,625 | 0 | |
| Dec 19 2016 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Option Exercise | M | 1.50 | 10,000 | 15,000 | 0 | |
| Dec 19 2016 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Option Exercise | M | 1.36 | 5,000 | 6,800 | 0 | |
| Dec 19 2016 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Sell | S | 15.28 | 1,875 | 28,644 | 9,375 | 11.3 K to 9.4 K (-16.67 %) |
| Dec 19 2016 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Buy | M | 1.50 | 3,750 | 5,625 | 11,250 | 7.5 K to 11.3 K (+50.00 %) |
| Dec 19 2016 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Sell | S | 15.19 | 5,000 | 75,973 | 7,500 | 12.5 K to 7.5 K (-40.00 %) |
| Dec 19 2016 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Buy | M | 1.50 | 10,000 | 15,000 | 12,500 | 2.5 K to 12.5 K (+400.00 %) |
| Dec 19 2016 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Sell | S | 15.26 | 2,500 | 38,156 | 2,500 | 5 K to 2.5 K (-50.00 %) |
| Dec 19 2016 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | SVP, Clinical Devel ... | Buy | M | 1.36 | 5,000 | 6,800 | 5,000 | 0 to 5 K |
| Dec 07 2016 | ITCI | Intra-Cellular The ... | ALAFI MOSHE | 10% Owner | Buy | P | 16.14 | 20,826 | 336,038 | 3,695,205 | 3.7 M to 3.7 M (+0.57 %) |
| Dec 07 2016 | ITCI | Intra-Cellular The ... | ALAFI MOSHE | 10% Owner | Buy | P | 16.33 | 44,174 | 721,445 | 3,674,379 | 3.6 M to 3.7 M (+1.22 %) |
| Dec 07 2016 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 16.14 | 20,826 | 336,038 | 3,695,205 | 3.7 M to 3.7 M (+0.57 %) |
| Dec 07 2016 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 16.33 | 44,174 | 721,445 | 3,674,379 | 3.6 M to 3.7 M (+1.22 %) |
| Dec 07 2016 | ITCI | Intra-Cellular The ... | ALAFI CAPITAL CO LLC | 10% Owner | Buy | P | 16.14 | 20,826 | 336,038 | 3,695,205 | 3.7 M to 3.7 M (+0.57 %) |
| Dec 07 2016 | ITCI | Intra-Cellular The ... | ALAFI CAPITAL CO LLC | 10% Owner | Buy | P | 16.33 | 44,174 | 721,445 | 3,674,379 | 3.6 M to 3.7 M (+1.22 %) |
| Nov 17 2016 | ITCI | Intra-Cellular The ... | ALAFI MOSHE | 10% Owner | Buy | P | 14.50 | 34,000 | 492,969 | 3,630,205 | 3.6 M to 3.6 M (+0.95 %) |
| Nov 17 2016 | ITCI | Intra-Cellular The ... | ALAFI CAPITAL CO LLC | 10% Owner | Buy | P | 14.50 | 34,000 | 492,969 | 3,630,205 | 3.6 M to 3.6 M (+0.95 %) |
| Nov 17 2016 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 14.50 | 34,000 | 492,969 | 3,630,205 | 3.6 M to 3.6 M (+0.95 %) |
| Oct 04 2016 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 0.00 | 951 | 0 | 31,670 | 30.7 K to 31.7 K (+3.10 %) |
| Oct 04 2016 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Grant | A | 0.00 | 902 | 0 | 4,886 | 4 K to 4.9 K (+22.64 %) |
| Oct 04 2016 | ITCI | Intra-Cellular The ... | VAN NOSTRAND ROBERT L | Director | Grant | A | 0.00 | 328 | 0 | 1,955 | 1.6 K to 2 K (+20.16 %) |
| Oct 04 2016 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 0.00 | 951 | 0 | 730,529 | 729.6 K to 730.5 K (+0.13 %) |
| Oct 04 2016 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Grant | A | 0.00 | 984 | 0 | 20,677 | 19.7 K to 20.7 K (+5.00 %) |
| Jul 05 2016 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 0.00 | 373 | 0 | 729,578 | 729.2 K to 729.6 K (+0.05 %) |
| Jul 05 2016 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Grant | A | 0.00 | 386 | 0 | 19,693 | 19.3 K to 19.7 K (+2.00 %) |
| Jul 05 2016 | ITCI | Intra-Cellular The ... | VAN NOSTRAND ROBERT L | Director | Grant | A | 0.00 | 128 | 0 | 1,627 | 1.5 K to 1.6 K (+8.54 %) |
| Jul 05 2016 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Grant | A | 0.00 | 354 | 0 | 3,984 | 3.6 K to 4 K (+9.75 %) |
| Jul 05 2016 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 0.00 | 373 | 0 | 30,719 | 30.3 K to 30.7 K (+1.23 %) |
| Jul 05 2016 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Grant | A | 0.00 | 354 | 0 | 3,984 | 3.6 K to 4 K (+9.75 %) |
| Jul 05 2016 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Grant | A | 0.00 | 354 | 0 | 3,984 | 3.6 K to 4 K (+9.75 %) |
| Jul 05 2016 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 0.00 | 373 | 0 | 30,719 | 30.3 K to 30.7 K (+1.23 %) |
| Jul 05 2016 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 0.00 | 373 | 0 | 30,719 | 30.3 K to 30.7 K (+1.23 %) |
| Jun 15 2016 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Option Exercise | A | 38.35 | 20,000 | 767,000 | 20,000 | |
| Jun 15 2016 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Option Exercise | A | 38.35 | 20,000 | 767,000 | 20,000 | |
| Jun 15 2016 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Option Exercise | A | 38.35 | 20,000 | 767,000 | 20,000 | |
| Jun 15 2016 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | A | 38.35 | 20,000 | 767,000 | 20,000 | |
| Jun 15 2016 | ITCI | Intra-Cellular The ... | VAN NOSTRAND ROBERT L | Director | Option Exercise | A | 38.35 | 20,000 | 767,000 | 20,000 | |
| Apr 04 2016 | ITCI | Intra-Cellular The ... | VAN NOSTRAND ROBERT L | Director | Grant | A | 0.00 | 134 | 0 | 1,499 | 1.4 K to 1.5 K (+9.82 %) |
| Apr 04 2016 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 0.00 | 382 | 0 | 16,061 | 15.7 K to 16.1 K (+2.44 %) |
| Apr 04 2016 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Grant | A | 0.00 | 386 | 0 | 19,307 | 18.9 K to 19.3 K (+2.04 %) |
| Apr 04 2016 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Grant | A | 0.00 | 364 | 0 | 3,630 | 3.3 K to 3.6 K (+11.15 %) |
| Apr 04 2016 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 0.00 | 377 | 0 | 729,205 | 728.8 K to 729.2 K (+0.05 %) |
| Feb 29 2016 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Buy | P | 29.70 | 100,000 | 2,970,300 | 728,828 | 628.8 K to 728.8 K (+15.90 %) |
| Feb 19 2016 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Option Exercise | M | 1.36 | 10,000 | 13,600 | 0 | |
| Feb 19 2016 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Buy | M | 1.36 | 10,000 | 13,600 | 47,500 | 37.5 K to 47.5 K (+26.67 %) |
| Jan 06 2016 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Option Exercise | A | 0.00 | 9,323 | 0 | 9,323 | |
| Jan 06 2016 | ITCI | Intra-Cellular The ... | Hineline Lawrence J. | VP of Finance CFO | Option Exercise | A | 53.63 | 39,307 | 2,108,034 | 39,307 | |
| Jan 06 2016 | ITCI | Intra-Cellular The ... | Halstead Michael | SVP and General Cou ... | Option Exercise | A | 0.00 | 9,323 | 0 | 9,323 | |
| Jan 06 2016 | ITCI | Intra-Cellular The ... | Halstead Michael | SVP and General Cou ... | Option Exercise | A | 53.63 | 39,307 | 2,108,034 | 39,307 | |
| Jan 06 2016 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | A | 0.00 | 19,811 | 0 | 19,811 | |
| Jan 06 2016 | ITCI | Intra-Cellular The ... | Mates Sharon | Chairman, President ... | Option Exercise | A | 53.63 | 83,528 | 4,479,607 | 83,528 | |
| Jan 06 2016 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | VP, Clinical Develo ... | Option Exercise | A | 0.00 | 4,661 | 0 | 4,661 | |
| Jan 06 2016 | ITCI | Intra-Cellular The ... | Vanover Kimberly E. | VP, Clinical Develo ... | Option Exercise | A | 53.63 | 19,653 | 1,053,990 | 19,653 | |
| Jan 05 2016 | ITCI | Intra-Cellular The ... | VAN NOSTRAND ROBERT L | Director | Grant | A | 53.79 | 69 | 3,712 | 1,365 | 1.3 K to 1.4 K (+5.32 %) |
| Jan 05 2016 | ITCI | Intra-Cellular The ... | RIGGS RORY B | Director | Grant | A | 53.79 | 197 | 10,597 | 15,679 | 15.5 K to 15.7 K (+1.27 %) |
| Jan 05 2016 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Grant | A | 53.79 | 188 | 10,113 | 3,266 | 3.1 K to 3.3 K (+6.11 %) |
| Jan 05 2016 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Grant | A | 53.79 | 199 | 10,704 | 18,921 | 18.7 K to 18.9 K (+1.06 %) |
| Jan 05 2016 | ITCI | Intra-Cellular The ... | Alafi Christopher D | Director | Grant | A | 53.79 | 195 | 10,489 | 628,828 | 628.6 K to 628.8 K (+0.03 %) |
| Dec 23 2015 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Option Exercise | G | 26.58 | 20,000 | 531,600 | 20,000 | |
| Dec 23 2015 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Option Exercise | G | 26.58 | 20,000 | 531,600 | 0 | |
| Dec 23 2015 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Option Exercise | G | 16.86 | 20,000 | 337,200 | 20,000 | |
| Dec 23 2015 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Option Exercise | G | 16.86 | 20,000 | 337,200 | 0 | |
| Dec 23 2015 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Option Exercise | G | 3.26 | 20,000 | 65,200 | 20,000 | |
| Dec 23 2015 | ITCI | Intra-Cellular The ... | LERNER RICHARD A | Director | Option Exercise | G | 3.26 | 20,000 | 65,200 | 0 |